Home › Cardiovascular Disease › NCT06747806
Biobank Cardiac Surgery
Biobank of Blood and Tissue Samples From Patients Undergoing Cardiac Surgery
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * All patients who undergo cardiac surgery at Advocate Children's Hospital (ACH)\& University of Chicago Medical Center (UCMC) by the ACH \& UC Cardiothoracic Surgery Research team who are pediatric neonates and up. * Patients will only be English speaking. Exclusion Criteria: * Vulnerable Subjects/Subject Capacity to provide consent
About the study
Treatment strategies for cardiac surgery patients have been evolving significantly for the last decade. While clinical outcomes have been improving, there are still significant areas unexplored in these patients. Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. It is often used to treat complications of ischemic heart disease (for example, with coronary artery bypass grafting); to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis.
Biobanking is a fundamental process required in the better understanding of human diseases together with their underlying mechanisms. Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve the understanding of health and disease. For this study, the investigator's objective is to acquire elucidation in disease etiology, translation, and advancing public health by evaluating blood and tissue results of those with cardiac disease undergoing cardiac surgery.
What is being tested
- Cardiac Surgery and Procedures (procedure)
Sponsor: University of Chicago · Participants: 500 · Started: Dec 18, 2023
Contact the study team
- Valluvan Jeevanandam, MD · Phone: 7738345087
- Leila Yazdanbakhsh · Phone: 7738345087
Official record on ClinicalTrials.gov — NCT06747806
Locations in the U.S.
| Illinois | The University of Chicago, Hyde Park |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.